bovin
coronaviru
occur
media
supplement
trypsin
singl
h
trypsin
treatment
h
later
infect
induc
format
polykaryon
trypsin
treatment
ph
induc
polykaryon
treatment
lower
higher
ph
level
cell
fusion
activ
partial
suppress
presenc
antibodi
infect
anim
cell
envelop
virus
involv
fusion
viral
envelop
cell
membran
fusogen
potenti
virus
studi
vitro
system
use
erythrocyt
cultur
cell
liposom
target
membran
membran
fusion
induc
paramyxovirus
neutral
ph
impli
virus
enter
host
cell
fusion
viral
envelop
plasma
membran
cell
surfac
contrast
cell
fusion
activ
semliki
forest
viru
influenza
viru
vesicular
stomat
viru
strictli
depend
acid
ph
level
low
ph
use
experiment
simul
condit
exist
within
acid
intracellular
vesicl
penetr
virus
thought
occur
cell
fusion
polykaryon
format
cultur
infect
bovin
coronaviru
bcv
occur
late
viru
replic
cycl
type
host
cell
polykaryocytosi
depend
presenc
trypsin
cours
bcv
replic
membran
event
virusinduc
cell
fusion
viruscel
fusion
entri
appear
base
principl
mode
bcv
penetr
host
cell
clearli
defin
analyz
trypsindepend
cell
fusion
bcvinfect
bf
cell
found
rang
ph
optim
polykaryon
format
stock
prepar
mebu
strain
bcv
propag
human
rectal
tumor
cell
line
viru
stock
gener
cell
infect
multipl
pfu
per
cell
incub
day
dulbecco
modifi
eagl
medium
dmem
buffer
mm
harvest
freezethaw
viral
titer
prepar
rang
l
pfu
per
ml
strain
bf
cell
maintain
minim
essenti
medium
mem
buffer
hepe
supplement
fetal
calf
serum
cell
monolay
grown
c
flask
analyz
effect
trypsin
trypsin
inhibitor
bcv
replic
cell
inocul
bcv
multipl
pfu
per
cell
incub
mem
contain
trypsin
ug
per
ml
sigma
chemic
compani
treat
chloromethyl
keton
inhibitor
chymotrypsin
activ
trypsintr
untreat
cultur
also
expos
soybean
trypsin
inhibitor
gg
per
ml
sigma
chemic
compani
period
trypsin
treatment
h
cultur
subject
two
freezethaw
cycl
disrupt
ice
sound
treatment
branson
sonic
power
compani
sec
releas
viru
viru
yield
determin
plaqu
assay
hemagglutin
assay
monolay
bf
cell
grown
plate
analysi
virusinduc
polykaryon
format
cultur
infect
multipl
pfu
per
cell
maintain
mem
without
addit
tg
soybean
trypsin
inhibitor
per
ml
cultur
incub
h
infect
fix
min
bouin
fix
stain
giemsa
cell
examin
microscop
x
object
extent
cell
fusion
score
count
number
polykaryon
nuclei
randomli
select
field
experi
conduct
identifi
time
period
fusion
bcvinfect
bf
cell
mediat
trypsin
infect
monolay
expos
trypsin
interv
period
viru
replic
h
monolay
fix
stain
score
polykaryon
format
effect
variou
ph
level
polykaryon
format
determin
monolay
infect
describ
incub
mem
buffer
mm
hepe
mm
me
ph
without
trypsin
cell
treat
h
tg
trypsin
per
ml
mem
variou
ph
level
trypsin
treatment
termin
monolay
incub
addit
h
trypsinfre
medium
ph
fixat
stain
antibodi
suppress
cell
fusion
test
igg
fraction
rabbit
antibcv
serum
normal
rabbit
serum
obtain
protein
asepharos
column
chromatographi
abil
antibcv
igg
affect
polykaryon
format
test
two
procedur
infect
cell
monolay
incub
h
trypsinfre
mem
expos
mem
contain
antibodi
freshli
dilut
trypsin
contain
medium
monolay
fix
stain
h
infect
ii
monolay
infect
h
treat
antibodi
h
absenc
trypsin
cell
cover
medium
contain
trypsin
antibodi
treatment
incub
addit
h
fix
polykaryon
format
bf
cell
requir
presenc
trypsin
time
viru
replic
cell
fusion
fail
occur
infect
cultur
without
trypsin
soybean
trypsin
inhibitor
present
trypsin
fig
singl
trypsin
treatment
later
infect
induc
format
polykaryon
polykaryon
gener
smaller
contain
fewer
nuclei
per
cell
fusion
product
continu
trypsin
treatment
interv
trypsin
treatment
end
prior
h
infect
produc
less
polykaryocytosi
fig
period
maxim
enhanc
trypsin
treatment
coincid
observ
onset
cell
fusion
cultur
treat
continu
trypsin
optim
time
may
relat
appear
critic
level
bcv
fusion
protein
cell
surfac
trypsin
treatment
began
induc
fewer
polykaryon
possibl
insuffici
time
avail
fuse
cell
coalesc
becom
visibl
multinucl
greatest
number
polykaryon
per
field
develop
monolay
treat
h
interv
period
h
infect
brief
trypsin
treatment
use
test
optim
activ
level
avoid
possibl
fluctuat
ph
might
occur
prolong
treatment
trypsin
treatment
result
polykaryocytosi
respect
treatment
media
lower
higher
ph
level
fail
support
polykaryon
develop
result
indic
fusion
function
bcv
depend
acid
condit
fusion
suppress
antibcv
antibodi
demonstr
two
differ
experiment
protocol
exposur
h
infect
medium
contain
trypsin
antibodi
reduc
polykaryon
format
greater
reduct
occur
infect
monolay
pretreat
antibodi
preincub
antibodi
trypsin
treatment
suppress
polykaryon
format
similar
infect
monolay
incub
normal
rabbit
serum
igg
suppress
antibodi
indic
coronavir
compon
involv
cell
fusion
trypsin
treatment
bcvinfect
bf
cell
time
maxim
fusion
enhanc
effect
media
ph
level
trypsin
ad
experi
gg
per
ml
level
fold
greater
need
cell
fusion
continu
treatment
ph
appar
ineffect
treatment
acid
ph
level
may
relat
optim
ph
rang
trypsin
activ
investig
necessari
determin
full
rang
ph
level
viral
fusion
protein
activ
result
thu
indic
bcvinduc
cell
fusion
occur
alkalin
ph
level
therefor
fusion
protein
bcv
strictli
depend
ph
level
less
activ
trypsintreat
pronounc
effect
bcv
infect
limit
viral
dilut
employ
st
cyrcoat
et
al
submit
public
amplif
bcv
infect
appar
unabl
account
trypsin
depend
cell
fusion
activ
treatment
trypsin
trypsin
inhibitor
condit
singl
cycl
viru
replic
increas
hemagglutin
titer
moder
effect
yield
infecti
viru
trypsin
modif
bcv
protein
appear
activ
viral
fusion
factor
without
produc
net
chang
total
number
infecti
particl
condit
viral
compon
respons
trypsinactiv
cell
fusion
like
express
plasmalemma
infect
cell
payn
et
al
submit
public
cell
infect
bcv
fuse
slightli
basic
environ
respect
fusogen
potenti
bcv
resembl
paramyxoviru
type
fusion
activ
trypsin
requir
bcv
fusion
factor
may
involv
matur
cleavag
coronavir
compon
analog
f
protein
hr
payn
j
storz
paramyxoviru
although
fusion
protein
bcv
clearli
identifi
recent
work
reveal
trypsin
treatment
bcvinfect
bf
cell
virion
purifi
system
modifi
kd
protein
bcv
envelop
concommit
emerg
kd
protein
chang
observ
reduc
condit
membran
fusion
activ
anoth
coronaviru
mous
hepat
viru
also
occur
neutral
slightli
alkalin
ph
level
like
paramyxovirus
coronavirus
may
capabl
penetr
host
cell
fusion
plasma
membran
infecti
entri
fusion
activ
alphavirus
rhabdovirus
orthomyxovirus
strictli
requir
exposur
viruscel
complex
acid
condit
cell
fusion
induc
physiolog
ph
paramyxovirus
either
among
cell
treat
condit
fusion
without
among
infect
cell
fusion
within
specif
glycoprotein
compon
f
paramyxoviru
envelop
known
involv
membran
fusion
activ
precursor
form
f
protein
express
surfac
nonpermiss
cell
activ
treatment
exogen
proteas
cleav
precursor
specif
site
